Enterprise Value

0.00

Cash

123.6M

Avg Qtr Burn

N/A

Short % of Float

0.00%

Insider Ownership

0.00%

Institutional Own.

0.00%

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Phase 2

Initiation

BI-1808 +/- KEYTRUDA Details
Advanced malignancies, Cancer

Phase 2a

Update

BI-1206 Details
Cancer, Solid tumor/s

Phase 1/2

Data readout

BI-1910 + KEYTRUDA Details
Solid tumor/s, Cancer

Phase 1/2

Update

BI-1607 Details
Solid tumor/s, Cancer

Phase 1

Data readout

BT-001 + KEYTRUDA Details
Solid tumor/s, Cancer

Phase 1

Data readout